Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shengtao Zhu

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
The American Journal of Gastroenterology|August 4, 2022
Response to Zhang et alShanshan Wu, Shengtao Zhu
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 10, 2024
ReplyShanshan Wu, Shengtao Zhu
Digestive Diseases and Sciences|July 25, 2022
Mucosal Microbiota: Closer to the Pathology, Closer to the Truth?Sian Xie, Shengtao Zhu, Li Min
Journal of Inflammation (London, England)|December 17, 2016
Ethyl pyruvate is a novel anti-inflammatory agent to treat multiple inflammatory organ injuriesRunkuan Yang, Shengtao Zhu, Tor Inge Tonnessen
Cancer Cell International|April 18, 2023
Retraction Note: Large tumor suppressor kinase 2 overexpression attenuates 5-FU-resistance in colorectal cancer via activating the JNK-MIEF1-mitochondrial division pathwayWeilong Yao, Shengtao Zhu, Peng Li, et al.
Cancer Cell International|April 24, 2019
Large tumor suppressor kinase 2 overexpression attenuates 5-FU-resistance in colorectal cancer via activating the JNK-MIEF1-mitochondrial division pathwayWeilong Yao, Shengtao Zhu, Peng Li, et al.
International Journal of Clinical and Experimental Pathology|October 15, 2015
The silence of p66(Shc) in HCT8 cells inhibits the viability via PI3K/AKT/Mdm-2/p53 signaling pathwayLing Zhang, Shengtao Zhu, Xuesen Shi, et al.
Journal of Translational Medicine|March 15, 2026
Harnessing γδ T cells for B7-H3-targeting CAR therapy to enhance anti-tumor therapy in glioblastomaHuantong Wu, Tingting Chen, Yajie Yu, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|January 8, 2021
Bile is a promising gut nutrient that inhibits intestinal bacterial translocation and promotes gut motility via an interleukin-6-related pathway in an animal model of endotoxemiaXiujing Sun, Shengtao Zhu, Tor Inge Tonnessen, et al.
DNA and Cell Biology|August 20, 2021
<i>HOXC11</i> Expression Is Associated with the Progression of Colon Adenocarcinoma and Is a Prognostic BiomarkerLinna Liu, Shujuan Jia, Xiaowei Jin, et al.
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
The American Journal of Gastroenterology|August 4, 2022
Response to Zhang et alShanshan Wu, Shengtao Zhu
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 10, 2024
ReplyShanshan Wu, Shengtao Zhu
Digestive Diseases and Sciences|July 25, 2022
Mucosal Microbiota: Closer to the Pathology, Closer to the Truth?Sian Xie, Shengtao Zhu, Li Min
Journal of Inflammation (London, England)|December 17, 2016
Ethyl pyruvate is a novel anti-inflammatory agent to treat multiple inflammatory organ injuriesRunkuan Yang, Shengtao Zhu, Tor Inge Tonnessen
Cancer Cell International|April 18, 2023
Retraction Note: Large tumor suppressor kinase 2 overexpression attenuates 5-FU-resistance in colorectal cancer via activating the JNK-MIEF1-mitochondrial division pathwayWeilong Yao, Shengtao Zhu, Peng Li, et al.
Cancer Cell International|April 24, 2019
Large tumor suppressor kinase 2 overexpression attenuates 5-FU-resistance in colorectal cancer via activating the JNK-MIEF1-mitochondrial division pathwayWeilong Yao, Shengtao Zhu, Peng Li, et al.
International Journal of Clinical and Experimental Pathology|October 15, 2015
The silence of p66(Shc) in HCT8 cells inhibits the viability via PI3K/AKT/Mdm-2/p53 signaling pathwayLing Zhang, Shengtao Zhu, Xuesen Shi, et al.
Journal of Translational Medicine|March 15, 2026
Harnessing γδ T cells for B7-H3-targeting CAR therapy to enhance anti-tumor therapy in glioblastomaHuantong Wu, Tingting Chen, Yajie Yu, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|January 8, 2021
Bile is a promising gut nutrient that inhibits intestinal bacterial translocation and promotes gut motility via an interleukin-6-related pathway in an animal model of endotoxemiaXiujing Sun, Shengtao Zhu, Tor Inge Tonnessen, et al.
DNA and Cell Biology|August 20, 2021
<i>HOXC11</i> Expression Is Associated with the Progression of Colon Adenocarcinoma and Is a Prognostic BiomarkerLinna Liu, Shujuan Jia, Xiaowei Jin, et al.
Pageof 14